Page last updated: 2024-11-07

tetrahydrocortisol and Cardiometabolic Syndrome

tetrahydrocortisol has been researched along with Cardiometabolic Syndrome in 1 studies

Cardiometabolic Syndrome: A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components not only include metabolic dysfunctions of METABOLIC SYNDROME but also HYPERTENSION, and ABDOMINAL OBESITY.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kobayashi, N1
Masuzaki, H1
Tanaka, T1
Nakao, K1

Reviews

1 review available for tetrahydrocortisol and Cardiometabolic Syndrome

ArticleYear
[The urinary index of intracellular glucocorticoid reactivation--a novel marker of metabolic syndrome and type 2 diabetes].
    Nihon rinsho. Japanese journal of clinical medicine, 2006, Dec-28, Volume: 64 Suppl 9

    Topics: Biomarkers; Diabetes Mellitus, Type 2; Humans; Metabolic Syndrome; Tetrahydrocortisol; Tetrahydrocor

2006
chemdatabank.com